Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference Transcript
Good morning, everybody. I'm Chris Schott from JPMorgan, and it's my pleasure to be introducing Teva today. From the company, we have CEO, Richard Francis. Richard has been at Teva for roughly three years in the company and the stock have had obviously a great run here. So looking forward to updates from Richard on progress of the business, and we'll jump into some Q&A after that.
So with that, over to Richard.
Thanks, Chris. Thanks for having us. Thank you, everybody, for coming. Absolute pleasure to be here today to talk about Teva Pharmaceuticals. Obviously, I represent everybody in the company. I just get the privilege to talk about it.
And today, I'm particularly pleased to be able to talk you through where we are on our pivot to growth strategy, a strategy we launched three years ago. And that strategy was designed to get Teva back to growth, obviously, the clues in the title there
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
